About T-box transcription factor TBX22
T-box transcription factor TBX22 (TBX22) is a protein
from Homo sapiens identified by UniProt accession
Q9Y458, 520 residues long.
MolForge cross-references it against 0 known binders and
88 disease associations.
Target properties
| Protein name | T-box transcription factor TBX22 |
| UniProt accession | Q9Y458 |
| Gene | TBX22 |
| Organism | Homo sapiens |
| Length | 520 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (88)
Diseases linked to this target (Open Targets).
- cleft palate with or without ankyloglossia, X-linked · score 0.75
- Abruzzo-Erickson syndrome · score 0.50
- neurodegenerative disease · score 0.42
- Cleft palate · score 0.41
- cleft palate · score 0.38
- cleft lip · score 0.37
- lysosomal storage disease · score 0.26
- Alzheimer disease · score 0.26
- Parkinson disease · score 0.26
- multiple sclerosis · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y458-F1 | alphafold | PREDICTED | 58.42 | — |
Amino-acid sequence (520 residues)
MALSSRARAF SVEALVGRPS KRKLQDPIQA EQPELREKKG GEEEEERRSS AAGKSEPLEK QPKTEPSTSA SSGCGSDSGY GNSSESLEEK DIQMELQGSE LWKRFHDIGT EMIITKAGRR MFPSVRVKVK GLDPGKQYHV AIDVVPVDSK RYRYVYHSSQ WMVAGNTDHL CIIPRFYVHP DSPCSGETWM RQIISFDRMK LTNNEMDDKG HIILQSMHKY KPRVHVIEQG SSVDLSQIQS LPTEGVKTFS FKETEFTTVT AYQNQQITKL KIERNPFAKG FRDTGRNRGV LDGLLETYPW RPSFTLDFKT FGADTQSGSS GSSPVTSSGG APSPLNSLLS PLCFSPMFHL PTSSLGMPCP EAYLPNVNLP LCYKICPTNF WQQQPLVLPA PERLASSNSS QSLAPLMMEV PMLSSLGVTN SKSGSSEDSS DQYLQAPNST NQMLYGLQSP GNIFLPNSIT PEALSCSFHP SYDFYRYNFS MPSRLISGSN HLKVNDDSQV SFGEGKCNHV HWYPAINHYL
Explore T-box transcription factor TBX22 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets